Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials completed
307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study